86
|
Novartis
small molecule splicing modulators Small Molecule Splicing Modulators, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/small+molecule+splicing+modulators/pmc12375692-368-1-5?v=Novartis Average 86 stars, based on 1 article reviews
small molecule splicing modulators - by Bioz Stars,
2026-08
86/100 stars
|
Buy from Supplier |
N/A
|
Nurulimab (anti-CTLA-4) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) humanized monoclonal antibody. Nurulimab (anti-CTLA-4) can be can be used in research of melanoma.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
|
Buy from Supplier |
N/A
|
CD33 Splicing Modulator 1（Cat No.:I044050）is a small-molecule compound that alters the splicing pattern of the CD33 gene, promoting the exclusion of exon 2 and thereby reducing expression of the full-length CD33 protein on the cell
|
Buy from Supplier |
N/A
|
Quavonlimab (anti-CTLA-4) is a novel anti-CTLA-4 antibody.Purity≥95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
|
Buy from Supplier |
N/A
|
Tremelimumab is an anti-CTLA-4 monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
|
Buy from Supplier |
N/A
|
Zalifrelimab (anti-CTLA-4) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab (anti-CTLA-4) antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
|
Buy from Supplier |
N/A
|
Spliceostatin A (CAT: I009788) is a natural product derived from the bacterium Pseudomonas chartarum. It is a potent inhibitor of pre-mRNA splicing, a crucial step in gene expression. Spliceostatin A targets the spliceosome, a large
|
Buy from Supplier |